Anúncio
Anúncio
ANIP
ANI Pharmaceuticals, Inc.
76.24
USDPatrocinado
-4.80
-5.92%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
76.94
+0.70
+0.92%
Relatórios de Lucros ANIP
Rácio de surpresa positiva
ANIP separação 26 de 40 últimas estimativas.
65%
Próximo Relatório
Data do Próximo Relatório
26 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$237.82M
/$2.07
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+4.39%
/+1.47%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+24.79%
/+26.99%
ANI Pharmaceuticals, Inc. earnings per share and revenue
On 07 de nov. de 2025, ANIP reported earnings of 2.04 USD per share (EPS) for Q3 25, beating the estimate of 1.78 USD, resulting in a 14.04% surprise. Revenue reached 227.81 milhão, compared to an expected 215.26 milhão, with a 5.83% difference. The market reacted with a +0.22% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analistas forecast an EPS of 2.07 USD, with revenue projected to reach 237.82 milhão USD, implying an aumentar of 1.47% EPS, and aumentar of 4.39% in Revenue from the last quarter.
FAQ
What were ANI Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, ANI Pharmaceuticals, Inc. reported EPS of $2.04, beating estimates by 14.04%, and revenue of $227.81M, 5.83% above expectations.
How did the market react to ANI Pharmaceuticals, Inc.'s Q3 2025 earnings?
The stock price moved up 0.22%, changed from $90.23 before the earnings release to $90.43 the day after.
When is ANI Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for 26 de fev. de 2026.
What are the forecasts for ANI Pharmaceuticals, Inc.'s next earnings report?
Based on 10
analistas, ANI Pharmaceuticals, Inc. is expected to report EPS of $2.07 and revenue of $237.82M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio